Clearstone focused on strategic partnerships & Asia in ‘11
Strategic partnerships and Asian expansion are the focus at Clearstone as it looks to grow revenues in its second year of operation.
Archives for February 17, 2011
Role for CROs as study deems cancer trials biggest risk for Pharmas
Late-stage cancer trials are the biggest challenge for pharmaceutical and biotech firms according to data presented at the Biotechnology Industry Organisation's (BIO) CEO and investor conference in Washington DC, US this week.
Capsugel buys FlexTab to expand into high value markets
Pfizer’s Capsugel unit has bought an injection molding technology that, it believes, will expand its capsule filling business into new “high value segments.”
Researchers warn Canadian trials patient info 'too easy to crack'
Passwords used to protect personal health information in Canadian clinical trials are often too easy to crack, according to a report in the Journal of Medical Internet Research (JMIR).
BioClinica service revenues up
BioClinica grew service revenues in the fourth quarter and predicted the trend will continue in 2011 when it will “eliminate certain duplicate functions”.
European Parliament votes yes on falsified medicines directive
The European Parliament has approved the falsified medicines directive and described it as a “huge step” in efforts to protect patients.
updated
CEO: Sanofi may provide Genzyme with fill/finish long term
Sanofi Aventis’ CEO, Chris Veibacher, said the French drugmaker may look at providing some fill/finish capacity for Genzyme in the long term.
Merck & Co may close Dutch Organon R&D lab
US drugmaker Merck & Co has not found a buyer for an R&D lab operated by its MSD-Organon division may consider closing the facility, according to a number of media reports.
BNC adds new consultants in China
BioNano Consulting (BNC) has signed up two new experts as part of an effort to build its presence in China.